These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Incidence of thrombotic complications in patients with haematological malignancies with central venous catheters: a prospective multicentre study. Cortelezzi A, Moia M, Falanga A, Pogliani EM, Agnelli G, Bonizzoni E, Gussoni G, Barbui T, Mannucci PM, CATHEM Study Group. Br J Haematol; 2005 Jun; 129(6):811-7. PubMed ID: 15953009 [Abstract] [Full Text] [Related]
10. Single-centre experience with tunnelled central venous catheters in 150 cancer patients. Koolen DA, van Laarhoven HW, Wobbes T, Punt CJ. Neth J Med; 2002 Nov; 60(10):397-401. PubMed ID: 12607590 [Abstract] [Full Text] [Related]
11. The impact of catheter-restricted filling with cefotaxime and heparin on the lifespan of temporary hemodialysis catheters: a case controlled study. Saxena AK, Panhotra BR. J Nephrol; 2005 Nov; 18(6):755-63. PubMed ID: 16358235 [Abstract] [Full Text] [Related]
14. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters. Koh DB, Gowardman JR, Rickard CM, Robertson IK, Brown A. Crit Care Med; 2008 Feb; 36(2):397-402. PubMed ID: 18216598 [Abstract] [Full Text] [Related]
18. The use of rifampicin-miconazole-impregnated catheters reduces the incidence of femoral and jugular catheter-related bacteremia. Lorente L, Lecuona M, Ramos MJ, Jiménez A, Mora ML, Sierra A. Clin Infect Dis; 2008 Nov 01; 47(9):1171-5. PubMed ID: 18808356 [Abstract] [Full Text] [Related]